Related Experiment Video

Updated: Aug 14, 2026

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
11:00

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

Interrelationship of magnesium and congestive heart failure

M S Seelig1

  • 1American College of Nutritrion, Decatur, Georgia 30033-2677, USA. MgSeelig@mindspring.com

Wiener Medizinische Wochenschrift (1946)
|December 6, 2000
PubMed

Insights

Maintaining adequate magnesium levels is crucial for preventing sudden cardiac death in patients with congestive heart failure. Supplementation and specific diuretics can reduce cardiac mortality in these high-risk individuals.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Nutritional Science

Background:

  • Congestive heart failure (CHF) is a significant risk factor for sudden cardiac death (SCD).
  • Diuretic therapy, commonly used in CHF management, can deplete essential electrolytes like magnesium.
  • Electrolyte imbalances, particularly low magnesium, are linked to increased arrhythmia risk in CHF patients.

Purpose of the Study:

  • To investigate the role of magnesium status in preventing sudden cardiac death in patients with congestive heart failure.
  • To evaluate the impact of specific diuretic strategies on cardiac mortality in CHF.
  • To support the premise that adequate magnesium levels are vital for cardiovascular health in CHF.

Main Methods:

  • Review of patient populations receiving long-term diuretic therapy.
  • Analysis of outcomes associated with potassium- and magnesium-sparing diuretics.
  • Assessment of the effects of magnesium supplementation on cardiac event rates.

Main Results:

  • Reduction in sudden cardiac death rates observed in patients on specific diuretic regimens.
  • Evidence suggests a correlation between adequate magnesium status and decreased cardiac mortality.
  • Potassium- and magnesium-sparing diuretics, along with magnesium supplements, were associated with improved outcomes.

Conclusions:

  • Maintenance of adequate magnesium status is important for preventing and managing cardiovascular diseases that predispose to congestive heart failure.
  • Specific diuretic choices and magnesium supplementation can mitigate the risk of sudden cardiac death in CHF patients.
  • Adequate magnesium is a key factor in reducing arrhythmia-related mortality in congestive heart failure.

More Related Videos

Magnetic Adjustment of Afterload in Engineered Heart Tissues09:40

Magnetic Adjustment of Afterload in Engineered Heart Tissues

Published on: May 5, 2020

Isolation of Human Ventricular Cardiomyocytes from Vibratome-Cut Myocardial Slices11:19

Isolation of Human Ventricular Cardiomyocytes from Vibratome-Cut Myocardial Slices

Published on: May 10, 2020

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.